Veterinary Medicine Information website

POLYGLOB, Injekční roztok

Not authorised
  • Immunoglobulins against Canine distemper virus, Canine
  • Immunoglobulins against Canine parvovirus, Canine
  • Immunoglobulins against Canine parainfluenza virus, Canine
  • Immunoglobulins against Canine adenovirus 1 and Canine adenovirus 2, Canine
Download as PDF

Product identification

Medicine name:
POLYGLOB, Injekční roztok
Active substance:
  • Immunoglobulins against Canine distemper virus, Canine
  • Immunoglobulins against Canine parvovirus, Canine
  • Immunoglobulins against Canine parainfluenza virus, Canine
  • Immunoglobulins against Canine adenovirus 1 and Canine adenovirus 2, Canine
Target species:
  • Dog
Route of administration:
  • Intravenous use
  • Intramuscular use

Product details

Active substance and strength:
  • Immunoglobulins against Canine distemper virus, Canine
    160.00
    virus neutralising unit(s)
    /
    1.00
    Dose
  • Immunoglobulins against Canine parvovirus, Canine
    1024.00
    haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
  • Immunoglobulins against Canine parainfluenza virus, Canine
    64.00
    haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
  • Immunoglobulins against Canine adenovirus 1 and Canine adenovirus 2, Canine
    160.00
    virus neutralising unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Solution for injection
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Czechia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/014/05-C
Date of authorisation status change: